
Mergin 0.125mg Tablet
Marketer
Shrinivas Gujarat Laboratories Pvt Ltd
Salt Composition
Methylergometrine (0.125mg)
Overview Mergin 0.125mg Tablet
Uterine bleeding following childbirth or termination of pregnancy may be managed with Mergin 0.125mg tablets. This medication enhances uterine smooth muscle tone, contraction rate, and strength, thereby minimizing blood loss. Mergin 0.125mg tablets may be ingested with or without food, but consistent timing optimizes efficacy. Dosage and frequency are determined by your physician based on individual needs and treatment goals. Administer as directed, swallowing whole with water. Continue treatment for the prescribed duration. Common adverse reactions include headache, elevated blood pressure, and convulsions. Report any concerning or severe symptoms to your doctor; management strategies may be available. Alcohol consumption should generally be avoided during treatment. Prior to commencing therapy, inform your physician of any pre-existing heart conditions or hypertension, and disclose all other medications currently in use, as interactions may affect Mergin's potency or mechanism of action.
Primary Ingredients of Mergin 0.125mg Tablet
There is no text provided to rephrase.
Uses of Mergin 0.125mg Tablet
Hemorrhage postpartum
Major Benefits of Mergin 0.125mg Tablet:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The 0.125mg Mergin tablet can be consumed with or without food, though consistent timing is recommended.
Common Side effects of Mergin 0.125mg Tablet:
- High blood pressure
- Headache
- Seizure
How to use Mergin 0.125mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The 0.125mg Mergin tablet can be consumed with or without food, although consistent timing is recommended.
How Mergin 0.125mg Tablet works:
Mergin 0.125mg tablets contain an ergot alkaloid that induces prolonged uterine smooth muscle contractions. This vascular compression effectively manages postpartum hemorrhage.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Mergin 0.125mg Tablet may pose unknown risks. Seek medical advice before combining them.
PregnancyUNSAFE
Use of Mergin 0.125mg tablets is strongly contraindicated during pregnancy. Pregnant individuals should consult their physician; research in animal and human studies reveals substantial risks to the fetus.
Breast feedingCAUTION
Use of Mergin 0.125mg Tablet while breastfeeding requires careful consideration. Mothers should discontinue breastfeeding throughout their treatment and until the medication is fully cleared from their system.
DrivingCONSULT YOUR DOCTOR
The impact of Mergin 0.125mg Tablet on driving ability is undetermined. Refrain from driving if any symptoms impair concentration or reaction time.
KidneyCONSULT YOUR DOCTOR
Data on Mergin 0.125mg Tablet use in patients with renal impairment is scarce. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Data regarding Mergin 0.125mg Tablet use in individuals with hepatic impairment is scarce. Physician consultation is advised.
What if you forget to take Mergin 0.125mg Tablet :
Should you forget a Mergin 0.125mg Tablet dose, take it immediately. If your next dose is nearly due, however, omit the missed dose and resume your usual dosing pattern. Never take a double dose.
Facts to Know About Mergin 0.125mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Ergoline alkaloids |
| Developing Habits | No. |
| Treatment Category | OBSTETRIC AND GYNECOLOGICAL |
| Actions | Drugs inducing uterine contraction and abortion |
